These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25979750)

  • 1. Estimating the dynamics and dependencies of accumulating mutations with applications to HIV drug resistance.
    Montazeri H; Günthard HF; Yang WL; Kouyos R; Beerenwinkel N;
    Biostatistics; 2015 Oct; 16(4):713-26. PubMed ID: 25979750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale inference of conjunctive Bayesian networks.
    Montazeri H; Kuipers J; Kouyos R; Böni J; Yerly S; Klimkait T; Aubert V; Günthard HF; Beerenwinkel N;
    Bioinformatics; 2016 Sep; 32(17):i727-i735. PubMed ID: 27587695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning monotonic genotype-phenotype maps.
    Beerenwinkel N; Knupfer P; Tresch A
    Stat Appl Genet Mol Biol; 2011; 10():Article 3. PubMed ID: 21291413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accommodating uncertainty in a tree set for function estimation.
    Healy BC; DeGruttola VG; Hu C
    Stat Appl Genet Mol Biol; 2008; 7(1):Article5. PubMed ID: 18312210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C.
    Posada-Céspedes S; Van Zyl G; Montazeri H; Kuipers J; Rhee SY; Kouyos R; Günthard HF; Beerenwinkel N
    PLoS Comput Biol; 2021 Sep; 17(9):e1008363. PubMed ID: 34491984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient sampling for Bayesian inference of conjunctive Bayesian networks.
    Sakoparnig T; Beerenwinkel N
    Bioinformatics; 2012 Sep; 28(18):2318-24. PubMed ID: 22782551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Bayesian and maximum-likelihood inference of population genetic parameters.
    Beerli P
    Bioinformatics; 2006 Feb; 22(3):341-5. PubMed ID: 16317072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering human immunodeficiency virus mutational pathways using temporal Bayesian networks.
    Hernandez-Leal P; Rios-Flores A; Avila-Rios S; Reyes-Terán G; Gonzalez JA; Fiedler-Cameras L; Orihuela-Espina F; Morales EF; Sucar LE
    Artif Intell Med; 2013 Mar; 57(3):185-95. PubMed ID: 23561488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint modeling of progression of HIV resistance mutations measured with uncertainty and failure time data.
    Hu C; De Gruttola V
    Biometrics; 2007 Mar; 63(1):60-8. PubMed ID: 17447930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying cancer progression with conjunctive Bayesian networks.
    Gerstung M; Baudis M; Moch H; Beerenwinkel N
    Bioinformatics; 2009 Nov; 25(21):2809-15. PubMed ID: 19692554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian and maximum likelihood estimation of genetic maps.
    York TL; Durrett RT; Tanksley S; Nielsen R
    Genet Res; 2005 Apr; 85(2):159-68. PubMed ID: 16174334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian restoration of ion channel records using hidden Markov models.
    Rosales R; Stark JA; Fitzgerald WJ; Hladky SB
    Biophys J; 2001 Mar; 80(3):1088-103. PubMed ID: 11222275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian experimental design for models with intractable likelihoods.
    Drovandi CC; Pettitt AN
    Biometrics; 2013 Dec; 69(4):937-48. PubMed ID: 24131221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian coestimation of phylogeny and sequence alignment.
    Lunter G; Miklós I; Drummond A; Jensen JL; Hein J
    BMC Bioinformatics; 2005 Apr; 6():83. PubMed ID: 15804354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximum likelihood and Bayesian methods for estimating the distribution of selective effects among classes of mutations using DNA polymorphism data.
    Bustamante CD; Nielsen R; Hartl DL
    Theor Popul Biol; 2003 Mar; 63(2):91-103. PubMed ID: 12615493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of HIV-1 pol sequences using Bayesian Networks: implications for drug resistance.
    Deforche K; Silander T; Camacho R; Grossman Z; Soares MA; Van Laethem K; Kantor R; Moreau Y; Vandamme AM;
    Bioinformatics; 2006 Dec; 22(24):2975-9. PubMed ID: 17021157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning multiple evolutionary pathways from cross-sectional data.
    Beerenwinkel N; Rahnenführer J; Däumer M; Hoffmann D; Kaiser R; Selbig J; Lengauer T
    J Comput Biol; 2005; 12(6):584-98. PubMed ID: 16108705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the scaled mutation rate and mutation bias with site frequency data.
    Vogl C
    Theor Popul Biol; 2014 Dec; 98():19-27. PubMed ID: 25453604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the rate of accumulating drug resistance mutations in the HIV genome.
    Braithwaite RS; Shechter S; Chang CC; Schaefer A; Roberts MS
    Value Health; 2007; 10(3):204-13. PubMed ID: 17532813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of the expectation-maximization (EM) algorithm for maximum likelihood estimation of gametic frequencies of multilocus polymorphic codominant systems based on sampled population data].
    Sergeev AS; Arapova RK
    Genetika; 2002 Mar; 38(3):407-18. PubMed ID: 11963570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.